MA49019A - Nouveaux modulateurs du récepteur sigma 2 et leur procédé d'utilisation - Google Patents

Nouveaux modulateurs du récepteur sigma 2 et leur procédé d'utilisation

Info

Publication number
MA49019A
MA49019A MA049019A MA49019A MA49019A MA 49019 A MA49019 A MA 49019A MA 049019 A MA049019 A MA 049019A MA 49019 A MA49019 A MA 49019A MA 49019 A MA49019 A MA 49019A
Authority
MA
Morocco
Prior art keywords
new sigma
receiver modulators
modulators
receiver
sigma
Prior art date
Application number
MA049019A
Other languages
English (en)
French (fr)
Inventor
Benjamin E Blass
Kevin M Blattner
Daniel J Canney
Original Assignee
Univ Temple
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Temple filed Critical Univ Temple
Publication of MA49019A publication Critical patent/MA49019A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D203/00Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • C07D307/33Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MA049019A 2017-03-21 2018-03-15 Nouveaux modulateurs du récepteur sigma 2 et leur procédé d'utilisation MA49019A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762474277P 2017-03-21 2017-03-21

Publications (1)

Publication Number Publication Date
MA49019A true MA49019A (fr) 2020-02-05

Family

ID=63585700

Family Applications (1)

Application Number Title Priority Date Filing Date
MA049019A MA49019A (fr) 2017-03-21 2018-03-15 Nouveaux modulateurs du récepteur sigma 2 et leur procédé d'utilisation

Country Status (5)

Country Link
US (3) US10961249B2 (https=)
EP (1) EP3600290B1 (https=)
JP (2) JP7365237B2 (https=)
MA (1) MA49019A (https=)
WO (1) WO2018175188A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2970223B1 (en) 2013-03-11 2020-04-15 Temple University Of The Commonwealth System Of Higher Education Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use
US10544117B2 (en) 2014-09-10 2020-01-28 Temple University—Of the Commonwealth System of Higher Education 5-hydroxytryptamine receptor 7 activity modulators and their method of use
AU2017361078B2 (en) 2016-11-15 2022-01-06 Praeventix, Llc Novel modulators of the 5-hydroxytryptamine receptor 7 and their method of use
MA49019A (fr) * 2017-03-21 2020-02-05 Univ Temple Nouveaux modulateurs du récepteur sigma 2 et leur procédé d'utilisation
MA49017A (fr) * 2017-03-21 2020-02-05 Univ Temple Modulateurs du récepteur 7 de la 5-hydroxytryptamine et utilisation de ces derniers en tant qu'agents thérapeutiques
EA202092328A1 (ru) 2018-05-11 2021-04-08 Темпл Юниверсити-Оф Зэ Коммонвелс Систем Оф Хаер Эдьюкейшн Новые функционализированные лактамы в качестве модуляторов 5-гидрокситриптаминового рецептора 7 и способ их применения
GB201809295D0 (en) 2018-06-06 2018-07-25 Institute Of Cancer Res Royal Cancer Hospital Lox inhibitors
CN112010859B (zh) * 2019-05-30 2022-07-19 中国科学院上海药物研究所 一种并环化合物、其制备方法和用途
CN120379996A (zh) * 2022-08-11 2025-07-25 瑞敏德股份有限公司 用于治疗神经退行性障碍的(氮杂)螺庚烷衍生物

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7435830B2 (en) * 2004-03-03 2008-10-14 Chemocentryx, Inc. Bicyclic and bridged nitrogen heterocycles
GB0419192D0 (en) 2004-08-27 2004-09-29 Merck Sharp & Dohme Therapeutic agents
KR20090112627A (ko) * 2006-11-13 2009-10-28 킹 파머슈티칼스 리서치 앤드 디벨로프먼트 아이엔씨 에이1 아데노신 수용체의 알로스테릭 조절제
US8148408B2 (en) * 2008-05-09 2012-04-03 Abbott Laboratories Selective substituted pyridine ligands for neuronal nicotinic receptors
US8697888B2 (en) * 2012-01-06 2014-04-15 Vanderbilt University Substituted (1-(methylsulfonyl)azetidin-3-yl)(heterocycloalkyl)methanone analogs as antagonists of muscarinic acetylcholine M1 receptors
WO2014085413A1 (en) 2012-11-28 2014-06-05 Temple University - Of The Commonwealth System Of Higher Education Disubstituted oxazolidin-2-ones 5-hydroxytryptamine receptor 2b activity modulators
AU2013355054B2 (en) 2012-12-07 2017-08-24 Chemocentryx, Inc. Diazole lactams
EP2970223B1 (en) * 2013-03-11 2020-04-15 Temple University Of The Commonwealth System Of Higher Education Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use
WO2014160592A2 (en) * 2013-03-27 2014-10-02 Merck Sharp & Dohme Corp. FACTOR XIa INHIBITORS
TN2016000203A1 (en) * 2013-12-20 2017-10-06 Esteve Labor Dr Piperazine derivatives having multimodal activity against pain.
US10544117B2 (en) 2014-09-10 2020-01-28 Temple University—Of the Commonwealth System of Higher Education 5-hydroxytryptamine receptor 7 activity modulators and their method of use
PE20171057A1 (es) * 2014-10-08 2017-07-21 Hoffmann La Roche Derivados espirodiamina como inhibidores de la aldosterona sintasa
AR103297A1 (es) 2014-12-30 2017-05-03 Forma Therapeutics Inc Pirrolo y pirazolopirimidinas como inhibidores de la proteasa 7 específica de ubiquitina
US20180221365A1 (en) * 2015-05-12 2018-08-09 Temple University-Of The Commonwealth System Of Higher Education Novel sigma-2 receptor binders and their method of use
AU2017361078B2 (en) 2016-11-15 2022-01-06 Praeventix, Llc Novel modulators of the 5-hydroxytryptamine receptor 7 and their method of use
MA49017A (fr) * 2017-03-21 2020-02-05 Univ Temple Modulateurs du récepteur 7 de la 5-hydroxytryptamine et utilisation de ces derniers en tant qu'agents thérapeutiques
MA49019A (fr) 2017-03-21 2020-02-05 Univ Temple Nouveaux modulateurs du récepteur sigma 2 et leur procédé d'utilisation
EA202092328A1 (ru) 2018-05-11 2021-04-08 Темпл Юниверсити-Оф Зэ Коммонвелс Систем Оф Хаер Эдьюкейшн Новые функционализированные лактамы в качестве модуляторов 5-гидрокситриптаминового рецептора 7 и способ их применения
JP7730811B2 (ja) 2019-11-13 2025-08-28 テンプル・ユニバーシティ-オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション 5-ヒドロキシトリプタミン受容体7の調節因子としての新規官能化ラクタムおよびその使用方法
WO2021097117A2 (en) 2019-11-13 2021-05-20 Temple University-Of The Commonwealth System Of Higher Education Novel functionalized lactones as modulators of the 5-hydroxytryptamine receptor 7 and their method of use

Also Published As

Publication number Publication date
US12577251B2 (en) 2026-03-17
JP2023168623A (ja) 2023-11-24
EP3600290A4 (en) 2020-08-12
WO2018175188A1 (en) 2018-09-27
EP3600290A1 (en) 2020-02-05
JP7781122B2 (ja) 2025-12-05
US20200039985A1 (en) 2020-02-06
US20240300954A1 (en) 2024-09-12
JP2020511506A (ja) 2020-04-16
US10961249B2 (en) 2021-03-30
JP7365237B2 (ja) 2023-10-19
EP3600290C0 (en) 2025-06-04
EP3600290B1 (en) 2025-06-04
US11820774B2 (en) 2023-11-21
US20210363145A1 (en) 2021-11-25

Similar Documents

Publication Publication Date Title
MA49019A (fr) Nouveaux modulateurs du récepteur sigma 2 et leur procédé d'utilisation
EP3344806A4 (en) GLYCANARRAYS AND METHOD OF USE
EP3310305A4 (en) BRANCHED AORTIC TRANSPLANT AND METHOD OF USE THEREOF
EP3541790A4 (en) NEW MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD FOR USE THEREOF
EP3368404A4 (en) SEPARATE TOWER JOINT ARRANGEMENT AND METHOD FOR USE THEREOF
EP3303634A4 (en) CAS9 VARIANTS AND METHOD FOR USE THEREOF
MA45996A (fr) Variants d'endonucléase de homing du récepteur alpha de l'il-10, compositions et méthodes d'utilisation associées
EP3385835A4 (en) METHOD AND DEVICE FOR CONFIGURING A ACCELERATOR
EP3394065A4 (en) TETRAHYDROPYRANYL-AMINO-PYRROLOPYRIMIDINONE AND METHOD OF USE THEREOF
MA43385A (fr) Nouveaux anticorps anti-claudine et méthodes d'utilisation
EP3371930A4 (en) METHOD AND DEVICE FOR SECURE AGGREGATED EVENT MESSAGE
EP3303435A4 (en) HYDROFLUOROLEFINES AND METHOD OF USE THEREOF
EP3816282A4 (en) LUCIFERIN BIOSYNTHETIC ENZYMES AND THEIR USE
EP3638037A4 (en) INSECTICIDAL PROTEINS FROM PLANTS AND METHOD OF USING THEM
EP3073705A4 (en) CHANNEL MANUFACTURING METHOD AND DEVICE
EP3604367A4 (en) BLOCK CO-POLYMER AND METHOD FOR MANUFACTURING A BLOCK CO-POLYMER
EP3632933A4 (en) Novel anti-cd40 antibodies and use thereof
EP3101933A4 (en) PHYSICAL CELL IDENTIFIER ASSIGNMENT METHOD AND DEVICE
EP3411046A4 (en) RAPAGLUTINES, NOVEL GLUT INHIBITORS AND USES THEREOF
EP3478052A4 (en) INSECTICIDE PROTEINS FROM PLANTS AND METHODS FOR THEIR USE
EP3386217A4 (en) AUDIO REPRODUCTION METHOD AND DEVICE THEREFOR
EP3852015A4 (en) SURGICAL ACCELERATOR AND COMPRESSION PROCEDURES
MA44087A (fr) Immunothérapie basée sur la listéria et ses méthodes d'utilisation
EP3528631A4 (en) PLANT INSECTICIDE PROTEINS AND METHOD FOR USE THEREOF
PL3509064T3 (pl) Urządzenie odbiorcze strumieni audio i sposób